DEBBIE MOORE: Open Payments
NPI 1316021926 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,066 in 17 payments from 8 companies in 2025. Trend: 2023 $2,344 · 2024 $820 · 2025 $1,066
Food & beverage: $1,066
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $299 |
| Otsuka America Pharmaceutical, Inc. | 2 | $233 |
| Alkermes, Inc. | 3 | $136 |
| Axsome Therapeutics, Inc. | 3 | $121 |
| Vanda Pharmaceuticals Inc. | 1 | $96 |
| Neurocrine BioSciences, Inc. | 1 | $86 |
| E.R. Squibb & Sons, L.L.C. | 1 | $77 |
| Lundbeck LLC | 1 | $18 |
Products named: CAPLYTA, REXULTI, Auvelity, LYBALVI, FANAPT, INGREZZA, COBENFY, ARISTADA.
Industry payments across TN — which companies pay providers there.
